{"AllianceGenome": "756", "HGNC": "756", "MIM": "608034", "_id": "443", "_version": 1, "accession": {"genomic": ["AC025125.15", "CH471108.2", "CP068261.2", "NC_000017.11", "NC_060941.1", "NG_008399.3", "S74727.1"], "protein": ["AAB29190.1", "AAD14981.1", "AAH29128.1", "BAG35747.1", "CAG46706.1", "EAW90506.1", "EAW90507.1", "NP_000040.1", "NP_001121557.1", "P45381.1", "XP_016880150.1", "XP_054172172.1"], "rna": ["AK312901.1", "BC010941.1", "BC029128.1", "CR541908.1", "NM_000049.4", "NM_001128085.1", "S67156.1", "XM_017024661.2", "XM_054316197.1"], "translation": [{"protein": "CAG46706.1", "rna": "CR541908.1"}, {"protein": "AAH29128.1", "rna": "BC029128.1"}, {"protein": "XP_016880150.1", "rna": "XM_017024661.2"}, {"protein": "NP_001121557.1", "rna": "NM_001128085.1"}, {"protein": "BAG35747.1", "rna": "AK312901.1"}, {"protein": "AAB29190.1", "rna": "S67156.1"}, {"protein": "XP_054172172.1", "rna": "XM_054316197.1"}, {"protein": "NP_000040.1", "rna": "NM_000049.4"}]}, "alias": ["ACY2", "ASP"], "clingen": {"_license": "https://www.clinicalgenome.org/docs/terms-of-use/", "clinical_validity": {"classification": "definitive", "classification_date": "2020-10-08T16:17:01.633Z", "disease_label": "Canavan disease", "gcep": "Aminoacidopathy Gene Curation Expert Panel", "moi": "AR", "mondo": "MONDO:0010079", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_66306eff-659f-4508-a41b-1820e47e0e1d-2020-10-08T161701.633Z", "sop": "SOP7"}}, "ec": "3.5.1.15", "ensembl": {"gene": "ENSG00000108381", "protein": ["ENSP00000263080", "ENSP00000409976", "ENSP00000458324", "ENSP00000461358"], "transcript": ["ENST00000263080", "ENST00000456349", "ENST00000571278", "ENST00000577034"], "translation": [{"protein": "ENSP00000458324", "rna": "ENST00000577034"}, {"protein": "ENSP00000409976", "rna": "ENST00000456349"}, {"protein": "ENSP00000263080", "rna": "ENST00000263080"}, {"protein": "ENSP00000461358", "rna": "ENST00000571278"}], "type_of_gene": "protein_coding"}, "entrezgene": "443", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 8.0139109606, "exp_mis": 94.8111948053, "exp_syn": 39.8457168021, "lof_z": 1.40454333458477, "mis_z": -0.662509702046868, "mu_lof": 5.24767554764e-07, "mu_mis": 8.69894135866e-06, "mu_syn": 3.55133512085e-06, "n_lof": 4.0, "n_mis": 108.0, "n_syn": 46.0, "p_li": 0.0148801566444315, "p_null": 0.109436748319813, "p_rec": 0.875683095035755, "syn_z": -0.604415886416459}, "bp": 942, "cds_end": 3402382, "cds_start": 3379453, "n_exons": 6, "nonpsych": {"exp_lof": 7.135628767, "exp_mis": 85.6955488799, "exp_syn": 35.9464824992, "lof_z": 1.15281735649431, "mis_z": -0.615930841414483, "mu_lof": 5.24767554764e-07, "mu_mis": 8.69894135866e-06, "mu_syn": 3.55133512085e-06, "n_lof": 4.0, "n_mis": 97.0, "n_syn": 45.0, "p_li": 0.0115332353749288, "p_null": 0.165434072911762, "p_rec": 0.823032691713309, "syn_z": -0.950720425719167}, "nontcga": {"exp_lof": 7.36132228973, "exp_mis": 87.214829345, "exp_syn": 36.6465827068, "lof_z": 1.22211904293053, "mis_z": -0.682057745254396, "mu_lof": 5.24767554764e-07, "mu_mis": 8.69894135866e-06, "mu_syn": 3.55133512085e-06, "n_lof": 4.0, "n_mis": 100.0, "n_syn": 43.0, "p_li": 0.0117425322042719, "p_null": 0.141423604925707, "p_rec": 0.846833862870022, "syn_z": -0.664527823344605}, "transcript": "ENST00000263080.2"}, "exons": [{"cdsend": 3499088, "cdsstart": 3476159, "chr": "17", "position": [[3475996, 3476395], [3481602, 3481798], [3483498, 3483592], [3489234, 3489342], [3494349, 3494459], [3498890, 3503405]], "strand": 1, "transcript": "NM_000049", "txend": 3503405, "txstart": 3475996}, {"cdsend": 3499088, "cdsstart": 3476159, "chr": "17", "position": [[3474109, 3474174], [3476133, 3476395], [3481602, 3481798], [3483498, 3483592], [3489234, 3489342], [3494349, 3494459], [3498890, 3499406]], "strand": 1, "transcript": "NM_001128085", "txend": 3499406, "txstart": 3474109}], "exons_hg19": [{"cdsend": 3402382, "cdsstart": 3379453, "chr": "17", "position": [[3379290, 3379689], [3384896, 3385092], [3386792, 3386886], [3392528, 3392636], [3397643, 3397753], [3402184, 3406699]], "strand": 1, "transcript": "NM_000049", "txend": 3406699, "txstart": 3379290}, {"cdsend": 3402382, "cdsstart": 3379453, "chr": "17", "position": [[3377403, 3377468], [3379427, 3379689], [3384896, 3385092], [3386792, 3386886], [3392528, 3392636], [3397643, 3397753], [3402184, 3402700]], "strand": 1, "transcript": "NM_001128085", "txend": 3402700, "txstart": 3377403}], "generif": [{"pubmed": 12638939, "text": "the ASPA gene was analysed in 22 unrelated non-Jewish patients with Canavan disease, and 24 different mutations were found"}, {"pubmed": 14699612, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 16437572, "text": "Mild-onset presentation of Canavan's disease associated with novel G212A point mutation in aspartoacylase gene"}, {"pubmed": 16669630, "text": "molecular weight of the purified enzyme is higher than predicted, suggesting the presence of post-translational modifications. Deglycosylation of aspartoacylase or mutation at glycosylation site causes decreased enzyme stability and catalytic activity"}, {"pubmed": 16935940, "text": "a green fluorescent protein-human ASPA fusion protein larger than the permissible size for the nuclear pore complex was enzymatically active and showed mixed nuclear-cytoplasmic distribution."}, {"pubmed": 17027983, "text": "The finding that wild-type and Glu178Asp have the same K(m) but different k(cat) values confirms the idea that the carboxylate group contributes importantly to the enzymatic activity of aspartoacylase."}, {"pubmed": 17194761, "text": "the N-terminal domain of aspartoacylase adopts a protein fold similar to that of zinc-dependent hydrolases related to carboxypeptidases A"}, {"pubmed": 17391648, "text": "These results show that aspartoacylase is a member of the caboxypeptidase A family and offer novel explanations for most loss-of-function aspartoacylase mutations associated with Canavan Disease."}, {"pubmed": 18264947, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 18293939, "text": "New structure of human aspartoacylase complexed with a catalytic intermediate analogue, N-phosphonomethyl- l-aspartate, supports a carboxypeptidase-type mechanism for hydrolysis of the amide bond of the substrate, N-acetyl- l-aspartate."}, {"pubmed": 20201926, "text": "Observational study and genome-wide association study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 22019069, "text": "We report on an Italian female patient with Canavan disease due to a missense mutation of the aspartoacylase gene and a 17p13.3 chromosomal microdeletion"}, {"pubmed": 22219087, "text": "Gene ASPA (NM_000049) was undertaken to sequence for mutation analysis."}, {"pubmed": 22468686, "text": "a novel mutation Y88X within the aspartoacylase gene in a consanguineous family with an affected child diagnosed as Canavan disease."}, {"pubmed": 22750302, "text": "Human aspartoacylase gene expression was high not only in brain and kidney, but also in lung and liver."}, {"pubmed": 22878930, "text": "This is the first case report of ASPA mutation studies in Canavan disease from Indian subcontinent."}, {"pubmed": 24036223, "text": "report of 2 Egyptian sibling patients suspected of Canavan disease (CD); study revealed homozygosity for substitution T530C (Ile177Thr) in exon 4 of the ASPA gene in both sibs; substitution T530C (Ile177Thr) results in a novel missense mutation causing a CD phenotype with severe clinical characteristics"}, {"pubmed": 24632142, "text": "Definitive evidence is presented to show that the recombinantly-expressed human aspartoacylase is not a glycoprotein."}, {"pubmed": 25003821, "text": "Four ASPA missense mutations associated with Canavan disease are structurally characterized."}, {"pubmed": 30431265, "text": "Allosteric Control of N-Acetyl-Aspartate Hydrolysis by the Y231C and F295S Mutants of Human Aspartoacylase"}, {"pubmed": 30834272, "text": "In one case, the homozygous pathogenic variant NM_000049.2:c.914C>A;p.Ala305Glu, which is previously reported in ClinVar, in the gene ASPA was identified causing Canavan disease. In the second case, the homozygous novel variant NM_000487.5:c.256C>G;p.Arg86Gly in the gene ARSA was identified causing metachromatic leukodystrophy."}, {"pubmed": 33914734, "text": "Mapping the degradation pathway of a disease-linked aspartoacylase variant."}, {"pubmed": 37391709, "text": "Aspartoacylase promotes the process of tumour development and is associated with immune infiltrates in gastric cancer."}], "genomic_pos": {"chr": "17", "end": 3503405, "ensemblgene": "ENSG00000108381", "start": 3472374, "strand": 1}, "genomic_pos_hg19": {"chr": "17", "end": 3406713, "start": 3375668, "strand": 1}, "go": {"BP": [{"evidence": "IEA", "gocategory": "BP", "id": "GO:0006083", "qualifier": "involved_in", "term": "acetate metabolic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0006531", "qualifier": "involved_in", "term": "aspartate metabolic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0022010", "qualifier": "involved_in", "term": "central nervous system myelination"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0048714", "qualifier": "involved_in", "term": "positive regulation of oligodendrocyte differentiation"}], "CC": [{"evidence": "IEA", "gocategory": "CC", "id": "GO:0005634", "qualifier": "located_in", "term": "nucleus"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005829", "qualifier": "is_active_in", "term": "cytosol"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005829", "qualifier": "located_in", "term": "cytosol"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005829", "qualifier": "located_in", "term": "cytosol"}], "MF": [{"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [22284616, 25416956, 25910212, 32296183, 32814053], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0016788", "qualifier": "enables", "term": "hydrolase activity, acting on ester bonds"}, {"category": "MF", "evidence": "IBA", "id": "GO:0016811", "qualifier": "enables", "term": "hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides"}, {"category": "MF", "evidence": "IDA", "id": "GO:0019807", "pubmed": 8252036, "qualifier": "enables", "term": "aspartoacylase activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0042802", "pubmed": [16189514, 17194761], "qualifier": "enables", "term": "identical protein binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0046872", "qualifier": "enables", "term": "metal ion binding"}]}, "homologene": {"genes": [[7955, 557232], [8364, 733935], [9031, 417609], [9544, 706170], [9598, 454430], [9606, 443], [9615, 611064], [9913, 509432], [10090, 11484], [10116, 79251]], "id": 33}, "interpro": [{"desc": "Succinylglutamate desuccinylase/aspartoacylase", "id": "IPR007036", "short_desc": "Aste_AspA"}, {"desc": "Aspartoacylase", "id": "IPR016708", "short_desc": "Aspartoacylase"}], "ipi": "IPI00021301", "map_location": "17p13.2", "name": "aspartoacylase", "other_names": ["ACY-2", "aminoacylase 2", "aspartoacylase", "cytosolic aspartoacylase"], "pantherdb": {"HGNC": "756", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "87914", "ortholog_type": "LDO", "panther_family": "PTHR15162", "taxid": 10090, "uniprot_kb": "Q8R3P0"}, {"RGD": "621693", "ortholog_type": "LDO", "panther_family": "PTHR15162", "taxid": 10116, "uniprot_kb": "Q9R1T5"}, {"Ensembl": "ENSGALG00000004669", "ortholog_type": "LDO", "panther_family": "PTHR15162", "taxid": 9031, "uniprot_kb": "E1BVP5"}, {"ZFIN": "ZDB-GENE-080204-11", "ortholog_type": "LDO", "panther_family": "PTHR15162", "taxid": 7955, "uniprot_kb": "A8KB34"}], "uniprot_kb": "P45381"}, "pathway": {"kegg": [{"id": "hsa00250", "name": "Alanine, aspartate and glutamate metabolism - Homo sapiens (human)"}, {"id": "hsa00340", "name": "Histidine metabolism - Homo sapiens (human)"}], "reactome": [{"id": "R-HSA-1430728", "name": "Metabolism"}, {"id": "R-HSA-71291", "name": "Metabolism of amino acids and derivatives"}, {"id": "R-HSA-8963693", "name": "Aspartate and asparagine metabolism"}], "smpdb": [{"id": "SMP00067", "name": "Aspartate Metabolism"}, {"id": "SMP00175", "name": "Canavan Disease"}, {"id": "SMP00192", "name": "Hypoacetylaspartia"}], "wikipathways": {"id": "WP106", "name": "Alanine and aspartate metabolism"}}, "pdb": ["2I3C", "2O4H", "2O53", "2Q51", "4MRI", "4MXU", "4NFR", "4TNU"], "pfam": "PF04952", "pharmgkb": "PA25055", "pharos": {"target_id": 13892, "tdl": "Tbio"}, "pir": "S38538", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF246051", "relationship": "is"}, {"id": "GNF246052", "relationship": "is"}, {"id": "GNF246053", "relationship": "is"}, {"id": "GNF246054", "relationship": "is"}], "GNF_hs-ORFeome1_1_reads": {"id": "GNF157316", "relationship": "is"}, "GNF_hs-Origene": {"id": "GNF031590", "relationship": "similar to"}, "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF079795", "relationship": "is"}, {"id": "GNF079796", "relationship": "is"}, {"id": "GNF079797", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF054536", "relationship": "is"}, {"id": "GNF059313", "relationship": "is"}, {"id": "GNF074687", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF069755", "relationship": "is"}, {"id": "GNF069756", "relationship": "is"}], "GNF_mm+hs-MGC": [{"id": "GNF000815", "relationship": "is"}, {"id": "GNF000816", "relationship": "is"}], "GNF_mm+hs_RetroCDNA": {"id": "GNF237343", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF108151", "relationship": "is"}, {"id": "GNF147792", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000017.11", "NC_060941.1", "NG_008399.3"], "protein": ["NP_000040.1", "NP_001121557.1", "XP_016880150.1", "XP_054172172.1"], "rna": ["NM_000049.4", "NM_001128085.1", "XM_017024661.2", "XM_054316197.1"], "translation": [{"protein": "XP_016880150.1", "rna": "XM_017024661.2"}, {"protein": "NP_000040.1", "rna": "NM_000049.4"}, {"protein": "NP_001121557.1", "rna": "NM_001128085.1"}, {"protein": "XP_054172172.1", "rna": "XM_054316197.1"}]}, "reporter": {"HG-U133_Plus_2": ["206030_at", "228807_at"], "HG-U95Av2": "39654_at", "HTA-2_0": ["TC17000033.hg.1", "TC17002016.hg.1"], "HuEx-1_0": ["2989096", "3706659"], "HuGene-1_1": "8003814", "HuGene-2_1": "16829728"}, "summary": "This gene encodes an enzyme that catalyzes the conversion of N-acetyl_L-aspartic acid (NAA) to aspartate and acetate. NAA is abundant in the brain where hydrolysis by aspartoacylase is thought to help maintain white matter. This protein is an NAA scavenger in other tissues. Mutations in this gene cause Canavan disease. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2008].", "symbol": "ASPA", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1412591"}, "unigene": "Hs.171142", "uniprot": {"Swiss-Prot": "P45381", "TrEMBL": ["I3L4M0", "Q6FH48", "I3L0T3"]}}